Ovid Therapeutics (OVID) Property, Plant & Equipment (Net) Growth (1y) (2017 - 2026)
Powered by 
Analysis
Ovid Therapeutics (OVID) Property, Plant & Equipment (Net) Growth (1y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 7.44% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 9.71% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 1.99% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 2.94% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 1.35% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 13.89% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 1.70% |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | -11.15% |
| 10 | Ovid Therapeutics | 517.32 Mn | 400.10 Mn | - | -29.47% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -29.47% |
| Mar 31, 2026 | -37.28% |
| Dec 31, 2025 | -41.80% |
| Sep 30, 2025 | -47.15% |
| Jun 30, 2025 | -53.88% |
| Mar 31, 2025 | -49.56% |
| Dec 31, 2024 | -43.69% |
| Sep 30, 2024 | -40.57% |
| Jun 30, 2024 | -35.33% |
| Mar 31, 2024 | -34.86% |
| Dec 31, 2023 | -33.01% |
| Sep 30, 2023 | -26.14% |
| Jun 30, 2023 | -23.13% |
| Mar 31, 2023 | 308.40% |
| Dec 31, 2022 | 372.89% |
| Sep 30, 2022 | 1,007.64% |
| Jun 30, 2022 | 993.70% |
| Mar 31, 2022 | 100.68% |
| Dec 31, 2021 | 79.00% |
| Sep 30, 2021 | -24.02% |